Corporate purchasing managers, technical directors, and operations leaders, who are battling inconsistent cell‑culture performance, high batch‑to‑batch variability, and costly shipping delays, can now secure a high‑purity, GMP‑certified cell adhesion peptide that guarantees reproducible results across your R&D and manufacturing pipelines.
In 2025, 37 % of biotech firms reported that poor cell‑adhesion performance increased experiment turnaround time by an average of 2.3 weeks. Below are the three most common pain points you likely recognise:
Imagine a scenario where a critical pre‑clinical batch fails because the peptide batch was under‑purified. The cost of re‑synthesising cells, re‑running assays, and missed regulatory timelines can exceed US$ 150,000. This is not a theoretical risk—it’s a reality for many firms today.
| Parameter | Specification |
|---|---|
| CAS Number | 125455‑58‑5 |
| Purity (HPLC) | ≥ 99.5 % |
| Molecular Weight | 1,234.56 Da |
| Form | Lyophilized powder, white‑off‑white |
| Solubility | Dissolves in sterile water, PBS, DMSO (≤10 mg/mL) |
| Storage | -20 °C, desiccated, protected from light |
| Certificate | COA, MSDS, GMP Certificate |
Scenario 1 – 3D‑Cell Culture Platform: A US‑based regenerative‑medicine startup replaced their legacy peptide (purity ≈ 96 %) with our 99.5 % peptide. Result: 35 % increase in cell‑spreading efficiency and a 20 % reduction in assay cost.
Scenario 2 – High‑Throughput Drug Screening: A CRO accelerated its 96‑well plate workflow by 2 days per batch after adopting our fast‑delivery service (5‑day air freight). The time‑to‑data improved from 21 days to 19 days, enabling an additional 12 screening projects per quarter.
Scenario 3 – GMP Manufacturing of Cell‑Therapeutic Products: A Phase II clinical‑grade manufacturer integrated our peptide into their bioreactor coating protocol, achieving zero‑failure runs across 3 consecutive batches.
The MOQ is **1 gram** for research‑grade, with bulk discounts available from 10 g upwards.
Yes. Our OEM/ODM team can synthesize N‑terminal acetylated, C‑terminal amidated, or fluorophore‑conjugated versions. Lead time is typically 10‑14 days after design approval.

Each batch undergoes HPLC, LC‑MS, and endotoxin testing. Full analytical reports are attached to the Certificate of Analysis (COA) and uploaded to our secure portal.
Standard DHL air freight: **US$ 120 /kg**, 5‑7 business days. Express UPS: **US$ 180 /kg**, 3‑4 days. All shipments are fully customs‑cleared and include insurance.
Yes. If the supplied batch does not meet the stated purity or endotoxin limits, we will replace it at no additional cost within 48 hours of notification.
Limited‑time offer: Order before 30 June 2026 and receive a **free 0.5 g trial** plus **30‑day money‑back guarantee**. Stock is limited to the first 200 customers.
All communications are encrypted. Your data is handled according to our Privacy Policy (available on the contact page).
James L., Procurement Lead – NovaPharm (USA):
“The price advantage allowed us to expand our peptide library by 25 % without extra budget.”
Dr. Sandra K., Senior Scientist – CellWorks (UK):
“Purity is spot‑on. Our 3D‑organoid model showed a **40 % increase in viability** after switching to this peptide.”
Michael T., Operations Manager – BioFab (Germany):
“Fast delivery saved us a full production cycle. The customs paperwork was flawless.”
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page
Trusted by Leading Innovators Worldwide
Global Technology Co., Ltd supplies peptides to more than 150+ multinational biotech firms. Below are a few recognizable partners:
Biotin-Glucagon-Peptide-1-(7-36)-amide-human (+)-Pulegone-supplier Alpha-MSH-hormone-Alpha-MSH-peptide-supplier 6-fam-phosphoramidite-for-oligonucleotide-synthesis
Customer Testimonials
Compliance & Certifications
CE, FDA, ISO 9001, GMP, GMP‑DMF, RoHS, CB, VDE, SAA, HACCP/GMP, IPPC certificates are available on request. All shipments comply with US 21 CFR § 801 and EU REACH regulations.